Centre de Rhumatologie de l'Est du Quebec

Rimouski, Quebec G5L 8W1

1 studies enrolling now · 5 studies all time

What they study most

Antiphospholipid Syndrome (APS), Arthritis, Psoriatic, Arthritis, Rheumatoid, Behçet's Syndrome (BS), Bullous Pemphigoid (BP), Dermatomyositis (DM), Immune Thrombocytopenia (ITP), Immune-mediated Necrotizing Myopathy (IMNM), Rheumatoid Arthritis

Studies at this site

• Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial) — Recruiting now
• Psoriatic Arthritis Dose Ranging Study for BMS-945429 in Subjects Who Are Not Responding to NSAIDs or Non-biologic Disease Modifying Anti-rheumatic Drugs (DMARDs) Therapy — Completed
• Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis — Completed
• A Pharmacokinetic/Pharmacodynamic Study Comparing PF-05280586 To Rituximab In Subjects With Active Rheumatoid Arthritis With An Inadequate Response To TNF Inhibitors (REFLECTIONS B328-01) — Completed
• Rheumatoid Arthritis Extension Trial For Subjects Who Have Participated In Other PF-05280586 Trials (REFLECTIONS B328-04) — Completed